← Evidence map

ArticleiScience2020

SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations.

Linda Pudelko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33305187